False claims risk undermining the Asia market for heart health products

By Gary Scattergood

- Last updated on GMT

"China, Indonesia and India" have particular problems with counterfeit claims
"China, Indonesia and India" have particular problems with counterfeit claims
Global and local players in Asia’s heart health sector are adopting radically different strategies – but dubious health claims from some of the latter threaten to undermine the market, according to an industry analyst.

Malarkodi Mahendran, a senior consultant at Future Market insights in India, analysed the varying approaches while highlighting the business opportunities for heart health products in the region.

She said every 20 seconds someone in Asia has a chronic heart episode.

“One-third of all deaths in region are caused by heart attack or stroke, and they account for 17% of all health costs in Asia,”​ she told the Vitafoods Conference in Hong Kong.

With Asian consumption of healthy oils compromising just 13% of the overall total, alongside rising sales of soft drinks, processed foods and excessive levels of salt intake, she said the market for functional foods for heart health was tipped to grow from US$340.2m today to US$665.7m by 2026.

“The drivers for this growth are the rising consumer awareness of health benefits, the trend of adopting prevention rather than cure, as well as the growing ageing population,”​ she said.

The current market for heart health products is dominated by Omega-3s, followed by beta-glucans, soya proteins, phytosterols and antioxidants, she added, before suggesting strawberry powder, algae, cocoa flavanols, and tomato extracts could soon make their presence felt in the market.

Staple focus

Predicting India, China and Japan to become the biggest growth markets for heart health products, Mahendran went on to add that the sector was split by the approaches of global manufacturers and local players.

While MNCs are more focused on launching new products with new flavours, domestic outfits are focusing on fortifying and reformulating local staple foods.

She said Nestlé and Kellogg had both launched new fortified heart health products in the region lately, with a clear focus on clean labels and proven health claims.

However, some domestic players persisted in making claims that were “not always legitimate.”

“China, Indonesia and India have particular problems with counterfeit claims. At the moment, many consumers are not aware that the claims are dubious,”​ she said, adding that it could ultimately undermine the market.

She suggested three factors that could help boost the fortunes of heart health products in Asia, namely expanding products to suit all price ranges, diversifying the product range away from breakfast cereals, edible oils and dairy goods, and educating consumers that functional foods are not just for people with existing health concerns, as is widely perceived to be case today.

Related news

Show more

Related products

show more

Xanthogreen®: High Efficacy, Fast acting Specialty

Xanthogreen®: High Efficacy, Fast acting Specialty

Content provided by Ennature Biopharma, a Division of India Glycols Limited | 15-Aug-2024 | Research Study

Xanthogreen® is a clinically validated, clean label ingredient from marigold flowers that helps boost your eye health with visible effects in as little...

Ingredients to support women at every life stage

Ingredients to support women at every life stage

Content provided by Gencor | 21-Jun-2024 | White Paper

While addressing women’s health across all stages of life, we might as well have opened Pandora’s box. Dietary supplements can play an important role in...

Pycnogenol® for a Healthy Summer

Pycnogenol® for a Healthy Summer

Content provided by Horphag Research | 07-Jun-2024 | White Paper

Pycnogenol® French maritime pine bark extract is the ideal ingredient for summer wellness with clinical research showing it helps mitigate allergy symptoms,...

Related suppliers

Follow us

Products

View more

Webinars

Nutra Champions Podcast